OTC Markets OTCPK - Delayed Quote USD

Cochlear Limited (CHEOY)

Compare
94.31
-0.22
(-0.23%)
At close: January 17 at 3:00:00 PM EST
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
2,235,600.00
2,235,600.00
1,936,100.00
1,648,300.00
1,497,600.00
Cost of Revenue
562,100.00
562,100.00
488,000.00
411,000.00
410,200.00
Gross Profit
1,673,500.00
1,673,500.00
1,448,100.00
1,237,300.00
1,087,400.00
Operating Expense
1,259,500.00
1,259,500.00
1,136,200.00
941,400.00
855,400.00
Operating Income
414,000.00
414,000.00
311,900.00
295,900.00
232,000.00
Net Non Operating Interest Income Expense
9,800.00
9,800.00
7,100.00
-6,200.00
-8,400.00
Other Income Expense
-23,900.00
-23,900.00
-3,300.00
31,100.00
62,600.00
Pretax Income
484,800.00
484,800.00
396,600.00
393,800.00
365,700.00
Tax Provision
128,000.00
128,000.00
96,000.00
104,700.00
39,200.00
Net Income Common Stockholders
356,800.00
356,800.00
300,600.00
289,100.00
326,500.00
Basic EPS
2.67
2.72
2.29
2.20
2.48
Diluted EPS
2.66
2.71
2.28
2.20
2.48
Basic Average Shares
131,328.27
131,073.42
131,524.89
131,540.88
131,466.54
Diluted Average Shares
131,743.32
131,418.05
131,813.20
131,540.88
131,466.54
Net Income from Continuing & Discontinued Operation
356,800.00
356,800.00
300,600.00
289,100.00
326,500.00
Normalized Income
356,800.00
356,800.00
300,600.00
289,100.00
326,500.00
Interest Income
19,000.00
19,000.00
16,500.00
2,400.00
3,600.00
Interest Expense
9,200.00
9,200.00
9,400.00
8,600.00
12,000.00
Net Interest Income
9,800.00
9,800.00
7,100.00
-6,200.00
-8,400.00
EBIT
494,000.00
494,000.00
406,000.00
402,400.00
377,700.00
EBITDA
578,900.00
578,900.00
486,900.00
475,400.00
457,200.00
Reconciled Cost of Revenue
562,100.00
562,100.00
488,000.00
411,000.00
410,200.00
Reconciled Depreciation
84,900.00
84,900.00
80,900.00
73,000.00
79,500.00
Net Income from Continuing Operation Net Minority Interest
356,800.00
356,800.00
300,600.00
289,100.00
326,500.00
Total Unusual Items Excluding Goodwill
-29,800.00
--
--
--
--
Total Unusual Items
-29,800.00
--
--
--
--
Normalized EBITDA
578,900.00
578,900.00
486,900.00
475,400.00
457,200.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
6/30/2021 - 4/5/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CVRX CVRx, Inc.
17.62
+1.85%
 
INGN Inogen, Inc.
10.47
-0.48%
 
PEN Penumbra, Inc.
263.69
+0.53%
 
GKOS Glaukos Corporation
156.39
-0.08%
 
ESTA Establishment Labs Holdings Inc.
34.56
-0.23%
 
IRTC iRhythm Technologies, Inc.
108.33
+1.25%
 
INSP Inspire Medical Systems, Inc.
177.68
+2.21%
 
PACB Pacific Biosciences of California, Inc.
1.6400
+2.50%
 
ABT Abbott Laboratories
113.48
-0.38%
 
TMDX TransMedics Group, Inc.
57.20
-1.41%